Pharmafile Logo

nusinersen

Impetus Digital Fireside Chat with Craig Lipset from Clinical Innovation Partners

Craig Lipset, Founder and Advisor at Clinical Innovation Partners and former Head of Clinical Innovation and Venture Partner at Pfizer, discusses everything from his personal health journey to his professional accomplishments,...

Impetus Digital

Impetus Digital Fireside Chat with Esther Schorr from Patient Power LLC

Esther Schorr, Co-founder and Chief Operating Officer of Patient Power, discusses her non-linear journey to patient education and Patient Power's mission to empower patients and their loved ones to take control...

Impetus Digital

Alzheimer’s: the search for a cure

Will Biogen’s aducanumab re-energise the hunt for pharma’s white whale?

- PMLiVE

Biogen joins COVID-19 efforts with $10m support fund

Funds will be used to address 'immediate critical needs'

- PMLiVE

Biogen bulks up in Alzheimer’s again with $2.7bn Sangamo deal

Gains rights to tau-targeting drug ST-501 as part of broader alliance

Assessing the value of interim analyses in clinical trials

Why its important and when its needed

- PMLiVE

Biogen triumphs over Mylan’s Tecfidera patent challenge

Shares in Biogen skyrocketed by 32% following ruling

- PMLiVE

Novartis faces criticism over Zolgensma ‘health lottery’

SMA Europe deems access programme 'inappropriate'

Blueberry Therapeutics receives clearance from the FDA to proceed with the clinical investigation of BB2603

Blueberry Therapeutics has received an investigational new drug (IND) clearance from the Food and Drug Administration (FDA) to proceed with the clinical development of BB2603

Onyx Health

- PMLiVE

Integrating electronic health records into clinical trials

How organisations are working to realise the research potential of EHRs

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links